vTv Therapeutics (VTVT) Times Interest Earned (2014 - 2026)
vTv Therapeutics (VTVT) posted Times Interest Earned of $1.12 for Q1 2026, up 102.78% sequentially from -$40.44 in Q4 2025, and up 102.23% YoY from $0.55 in Q1 2025.
vTv Therapeutics (VTVT) Times Interest Earned (2014 - 2026) Analysis & Trends
vTv Therapeutics has reported Times Interest Earned for 13 years, with the latest figure at $1.12 in Q1 2026.
- Quarterly Times Interest Earned rose 102.23% year-over-year to $1.12 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.15 (up 99.92% YoY) and the FY2025 annual result came in at -$0.65, up 7.89% from the prior year.
- Times Interest Earned advanced to $1.12 in Q1 2026 per VTVT's latest filing, from -$40.44 in the prior quarter.
- Over five years, Times Interest Earned peaked at $1.12 in Q1 2026 and troughed at -$2446.0 in Q4 2024.
- A 5-year average of -$435.39 and a median of -$26.11 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2025 and 2026: Times Interest Earned slumped 7300.17% in 2025, then jumped 102.23% in 2026.
- Over 5 years, Times Interest Earned stood at -$1057.2 in 2022, then jumped by 36.39% to -$672.43 in 2023, then tumbled by 263.76% to -$2446.0 in 2024, then surged by 98.35% to -$40.44 in 2025, then jumped by 102.78% to $1.12 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $1.12, -$40.44, and -$2139.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | vTv Therapeutics | 373.77 Mn | 373.77 Mn | - | -0.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.78 |
| Mar 31, 2026 | 1.12 |
| Dec 31, 2025 | -40.44 |
| Sep 30, 2025 | -2,139.80 |
| Mar 31, 2025 | -50.41 |
| Dec 31, 2024 | -2,446.00 |
| Sep 30, 2024 | -28.92 |
| Jun 30, 2024 | -26.11 |
| Mar 31, 2024 | -17.48 |
| Dec 31, 2023 | -672.43 |
| Sep 30, 2023 | -12.81 |
| Jun 30, 2023 | -17.09 |
| Dec 31, 2022 | -1,057.17 |
| Sep 30, 2022 | -9.02 |
| Jun 30, 2022 | -5.78 |
| Mar 31, 2022 | -8.51 |
| Dec 31, 2021 | -1,851.50 |
| Sep 30, 2021 | -1.80 |
| Jun 30, 2021 | -4.89 |
| Mar 31, 2021 | -15.56 |